Browse by author
Lookup NU author(s): Professor David Ellison
Ependymal tumors constitute a clinicopathologically heterogeneous group of brain tumors. They vary in regard to their age at first symptom, localization, morphology and prognosis. Genetic data also suggests heterogeneity. We define a newly recognized subset of ependymal tumors, the trisomy 19 ependymoma. Histologically, they are compact lesions characterized by a rich branched capillary network amongst which tumoral cells are regularly distributed. When containing clear cells they are called clear cell ependymoma. Most trisomy 19 ependymomas are supratentorial WHO grade III tumors of the young. Genetically, they are associated with trisomy 19, and frequently with a deletion of 13q21.31-31.2, three copies of 11q13.3-13.4, and/or deletions on chromosome 9. These altered chromosomal regions are indicative of genes and pathways involved in trisomy 19 ependymoma tumorigenesis. Recognition of this genetico-histological entity allows better understanding and dissection of ependymal tumors. © 2007 Rousseau et al; licensee BioMed Central Ltd.
Author(s): Rousseau E, Palm T, Scaravilli F, Ruchoux M-M, Figarella-Branger D, Salmon I, Ellison D, Lacroix C, Chapon F, Mikol J, Vikkula M, Godfraind C
Publication type: Article
Publication status: Published
Journal: Molecular Cancer
Date deposited: 04/06/2010
ISSN (print): 1476-4598
Publisher: BioMed Central Ltd.
PubMed id: 17626628
Altmetrics provided by Altmetric